The Cigna Corp (CI)

$334.8

+0.9

(+0.27%)

Market is closed - opens 7 PM, 20 Jun 2024
star icon

Cigna Corp is a global health service company that provides medical, dental, and disability insurance plans.

Insights on The Cigna Corp

  • Increasing Revenue

    Revenue is up for the last 7 quarters, 45.19B → 55.41B (in $), with an average increase of 3.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 1.02B → -277.0M (in $), with an average decrease of 126.9% per quarter

Performance

  • $333.64
    $337.54
    $334.80
    downward going graph

    0.35%

    Downside

    Day's Volatility :1.16%

    Upside

    0.81%

    downward going graph
  • $251.86
    $364.21
    $334.80
    downward going graph

    24.77%

    Downside

    52 Weeks Volatility :30.85%

    Upside

    8.08%

    downward going graph

Returns

PeriodThe Cigna CorpSector (Health Care)S&P500
3 Months
-5.31%
0.6%
6.3%
6 Months
14.32%
8.9%
15.5%
1 Year
23.64%
10.2%
24.1%
3 Years
43.94%
17.8%
31.4%

Highlights

Market Capitalization
94.7B
Book Value
$144.9
Dividend Share
5.09
Dividend Yield
1.68%
Earnings Per Share (EPS)
12.17
PE Ratio
27.39
PEG Ratio
0.89
Wall Street Target Price
391.36
Profit Margin
1.77%
Operating Margin TTM
0.81%
Return On Assets TTM
3.08%
Return On Equity TTM
8.97%
Revenue TTM
204.1B
Revenue Per Share TTM
700.13
Quarterly Revenue Growth YOY
19.3%
Gross Profit TTM
23.0B
EBITDA
9.2B
Diluted Eps TTM
12.17
Quarterly Earnings Growth YOY
-0.1
EPS Estimate Current Year
28.52
EPS Estimate Next Year
32.05
EPS Estimate Current Quarter
6.22
EPS Estimate Next Quarter
6.93

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 32 Wall street analysts offering stock ratings for The Cigna Corp(by analysts ranked 0 to 5 stars)
Based on 32 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
26
26
20
Hold
6
6
10
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 16.89%

Current $334.80
Target $391.36

Company Financials

FY18Y/Y Change
Revenue
48.6B
↑ 15.52%
Net Income
2.6B
↑ 17.88%
Net Profit Margin
5.43%
↑ 0.11%
FY19Y/Y Change
Revenue
153.7B
↑ 216.55%
Net Income
5.1B
↑ 93.55%
Net Profit Margin
3.32%
↓ 2.11%
FY20Y/Y Change
Revenue
160.6B
↑ 4.45%
Net Income
8.5B
↑ 65.71%
Net Profit Margin
5.27%
↑ 1.95%
FY21Y/Y Change
Revenue
174.3B
↑ 8.53%
Net Income
5.4B
↓ 36.51%
Net Profit Margin
3.08%
↓ 2.19%
FY22Y/Y Change
Revenue
180.6B
↑ 3.66%
Net Income
6.7B
↑ 24.84%
Net Profit Margin
3.71%
↑ 0.63%
FY23Y/Y Change
Revenue
195.2B
↑ 8.05%
Net Income
5.2B
↓ 22.97%
Net Profit Margin
2.65%
↓ 1.06%
Q4 FY22Q/Q Change
Revenue
45.8B
↑ 1.22%
Net Income
1.2B
↓ 57.6%
Net Profit Margin
2.56%
↓ 3.54%
Q1 FY23Q/Q Change
Revenue
46.5B
↑ 1.55%
Net Income
1.3B
↑ 8.38%
Net Profit Margin
2.73%
↑ 0.17%
Q2 FY23Q/Q Change
Revenue
48.6B
↑ 4.64%
Net Income
1.5B
↑ 15.23%
Net Profit Margin
3.0%
↑ 0.27%
Q3 FY23Q/Q Change
Revenue
49.0B
↑ 0.89%
Net Income
41.0M
↓ 97.19%
Net Profit Margin
0.08%
↓ 2.92%
Q4 FY23Q/Q Change
Revenue
51.1B
↑ 4.14%
Net Income
1.0B
↑ 2409.76%
Net Profit Margin
2.01%
↑ 1.93%
Q1 FY24Q/Q Change
Revenue
55.4B
↑ 8.49%
Net Income
-277.0M
↓ 126.92%
Net Profit Margin
-0.5%
↓ 2.51%
FY18Y/Y Change
Total Assets
153.2B
↑ 148.13%
Total Liabilities
112.2B
↑ 133.81%
FY19Y/Y Change
Total Assets
155.8B
↑ 1.66%
Total Liabilities
110.4B
↓ 1.57%
FY20Y/Y Change
Total Assets
155.5B
↓ 0.21%
Total Liabilities
105.1B
↓ 4.83%
FY21Y/Y Change
Total Assets
154.9B
↓ 0.36%
Total Liabilities
107.7B
↑ 2.51%
FY22Y/Y Change
Total Assets
143.9B
↓ 7.07%
Total Liabilities
99.0B
↓ 8.1%
FY23Y/Y Change
Total Assets
147.9B
↑ 2.77%
Total Liabilities
101.6B
↑ 2.62%
Q4 FY22Q/Q Change
Total Assets
143.9B
↓ 0.19%
Total Liabilities
99.0B
↓ 0.1%
Q1 FY23Q/Q Change
Total Assets
148.0B
↑ 2.81%
Total Liabilities
103.4B
↑ 4.44%
Q2 FY23Q/Q Change
Total Assets
150.1B
↑ 1.4%
Total Liabilities
104.5B
↑ 1.11%
Q3 FY23Q/Q Change
Total Assets
149.6B
↓ 0.27%
Total Liabilities
103.9B
↓ 0.62%
Q4 FY23Q/Q Change
Total Assets
147.9B
↓ 1.15%
Total Liabilities
101.6B
↓ 2.22%
Q1 FY24Q/Q Change
Total Assets
148.4B
↑ 0.35%
Total Liabilities
107.1B
↑ 5.44%
FY18Y/Y Change
Operating Cash Flow
3.8B
↓ 7.73%
Investing Cash Flow
-26.4B
↑ 1448.91%
Financing Cash Flow
23.5B
↓ 987.02%
FY19Y/Y Change
Operating Cash Flow
9.5B
↑ 151.59%
Investing Cash Flow
-734.0M
↓ 97.22%
Financing Cash Flow
-7.2B
↓ 130.56%
FY20Y/Y Change
Operating Cash Flow
10.4B
↑ 9.12%
Investing Cash Flow
3.0B
↓ 505.45%
Financing Cash Flow
-8.5B
↑ 18.73%
FY21Y/Y Change
Operating Cash Flow
7.2B
↓ 30.52%
Investing Cash Flow
-3.6B
↓ 221.34%
Financing Cash Flow
-8.2B
↓ 3.76%
FY22Y/Y Change
Operating Cash Flow
8.7B
↑ 20.37%
Investing Cash Flow
3.1B
↓ 185.79%
Financing Cash Flow
-11.2B
↑ 36.87%
Q4 FY22Q/Q Change
Operating Cash Flow
2.1B
↓ 36.06%
Investing Cash Flow
3.1B
↓ 30.32%
Financing Cash Flow
-2.6B
↓ 52.22%
Q1 FY23Q/Q Change
Operating Cash Flow
5.0B
↑ 139.54%
Investing Cash Flow
-3.0B
↓ 196.29%
Financing Cash Flow
-37.0M
↓ 98.6%
Q2 FY23Q/Q Change
Operating Cash Flow
2.5B
↓ 50.44%
Investing Cash Flow
-414.0M
↓ 86.12%
Financing Cash Flow
-435.0M
↑ 1075.68%
Q3 FY23Q/Q Change
Operating Cash Flow
2.8B
↑ 13.4%
Investing Cash Flow
-4.7B
↑ 1043.48%
Financing Cash Flow
-2.6B
↑ 491.26%

Technicals Summary

Sell

Neutral

Buy

The Cigna Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
The Cigna Corp
The Cigna Corp
0.16%
14.32%
23.64%
43.94%
108.9%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
-5.41%
-7.09%
4.23%
25.65%
99.12%
Cvs Health Corporation
Cvs Health Corporation
6.43%
-18.42%
-11.04%
-25.86%
11.76%
Humana Inc.
Humana Inc.
0.01%
-22.78%
-20.47%
-16.12%
37.72%
Elevance Health, Inc
Elevance Health, Inc
-1.34%
13.85%
22.02%
44.74%
85.34%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
The Cigna Corp
The Cigna Corp
27.39
27.39
0.89
28.52
0.09
0.03
0.02
144.9
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
30.39
30.39
1.24
27.61
0.17
0.07
0.02
94.23
Cvs Health Corporation
Cvs Health Corporation
10.56
10.56
1.0
7.03
0.1
0.03
0.04
59.08
Humana Inc.
Humana Inc.
22.13
22.13
1.64
16.34
0.12
0.05
0.01
133.86
Elevance Health, Inc
Elevance Health, Inc
20.16
20.16
1.14
37.28
0.16
0.06
0.01
174.62
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
The Cigna Corp
The Cigna Corp
Buy
$94.7B
108.9%
27.39
1.77%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$457.5B
99.12%
30.39
4.05%
Cvs Health Corporation
Cvs Health Corporation
Buy
$75.6B
11.76%
10.56
2.04%
Humana Inc.
Humana Inc.
Buy
$43.3B
37.72%
22.13
1.82%
Elevance Health, Inc
Elevance Health, Inc
Buy
$124.3B
85.34%
20.16
3.64%

Institutional Holdings

  • Vanguard Group Inc

    9.43%
  • BlackRock Inc

    8.56%
  • FMR Inc

    5.06%
  • T. Rowe Price Associates, Inc.

    5.05%
  • State Street Corporation

    4.69%
  • Dodge & Cox

    4.62%

Corporate Announcements

  • The Cigna Corp Dividends March,2024

    In the quarter ending March,2024. The Cigna Corp has declared dividend of $1.4

    Read More

Company Information

The Cigna Group is a global health services company. The Companys portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare.

Organization
The Cigna Corp
Employees
70325
CEO
Mr. David Michael Cordani
Industry
Health Services

FAQs